Dr Kent J Stock, DO - Medicare Internal Medicine in Charleston, SC

Dr Kent J Stock, DO is a medicare enrolled "Internal Medicine - Infectious Disease" physician in Charleston, South Carolina. He went to New York College Of Osteo Medicine Of New York Institute Of Technology and graduated in 1991 and has 33 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Lowcountry Infectious Diseases Pa, Southeastern Hospitalist Services Pc and his current practice location is 1938 B Charlie Hall Blvd, Charleston, South Carolina. You can reach out to his office (for appointments etc.) via phone at (843) 402-0227.

Dr Kent J Stock is licensed to practice in South Carolina (license number 0533) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1356331904.

Contact Information

Dr Kent J Stock, DO
1938 B Charlie Hall Blvd,
Charleston, SC 29414-5837
(843) 402-0227
(843) 402-0232



Physician's Profile

Full NameDr Kent J Stock
GenderMale
SpecialityInternal Medicine
Experience33 Years
Location1938 B Charlie Hall Blvd, Charleston, South Carolina
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Kent J Stock attended and graduated from New York College Of Osteo Medicine Of New York Institute Of Technology in 1991
  NPI Data:
  • NPI Number: 1356331904
  • Provider Enumeration Date: 10/25/2005
  • Last Update Date: 01/14/2011
  Medicare PECOS Information:
  • PECOS PAC ID: 4981766797
  • Enrollment ID: I20090102000125

Medical Identifiers

Medical identifiers for Dr Kent J Stock such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1356331904NPI-NPPES
GP1016MedicaidSC

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RI0200XInternal Medicine - Infectious Disease 0533 (South Carolina)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Roper HospitalCharleston, SCHospital
Bon Secours-st Francis Xavier HospitalCharleston, SCHospital
Mount Pleasant HospitalMount pleasant, SCHospital
Colleton Medical CenterWalterboro, SCHospital
Beaufort County Memorial HospitalBeaufort, SCHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Lowcountry Infectious Diseases Pa852707029113
Southeastern Hospitalist Services Pc3476855420276

News Archive

HHS awards $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines

United States Department of Health and Human Services has awarded a $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines for the U.S.

Uric acid may provide early clues to diabetic kidney disease

For patients with type 1 diabetes, increased levels of uric acid in the blood may be an early sign of diabetic kidney disease - appearing before any significant change in urine albumin level, the standard screening test, reports a study in the May 2008 issue of the Clinical Journal of the American Society of Nephrology.

Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia

Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that they have entered into an agreement providing Astellas exclusive rights to develop and commercialize the investigational compound linaclotide in Japan, Indonesia, Korea, the Philippines, Taiwan, and Thailand.

New insight into how brain responds when people experience an unexpected or traumatic event

In a new study, psychologists at the University of Alabama at Birmingham (UAB) are able to see in detail for the first time how various regions of the human brain respond when people experience an unexpected or traumatic event. The study could lead to the creation of biological measures that could identify people with post-traumatic stress disorder (PTSD) or identify PTSD sufferers who would benefit from specific treatments.

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

As the number of children with severe COVID-19 illness grows, there is increasing urgency to ensure that potential treatments and vaccines are tested for safety and efficacy in children.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Kent J Stock allows following entities to bill medicare on his behalf.
Entity NameLowcountry Infectious Diseases Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1194778548
PECOS PAC ID: 8527070291
Enrollment ID: O20060620000209

News Archive

HHS awards $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines

United States Department of Health and Human Services has awarded a $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines for the U.S.

Uric acid may provide early clues to diabetic kidney disease

For patients with type 1 diabetes, increased levels of uric acid in the blood may be an early sign of diabetic kidney disease - appearing before any significant change in urine albumin level, the standard screening test, reports a study in the May 2008 issue of the Clinical Journal of the American Society of Nephrology.

Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia

Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that they have entered into an agreement providing Astellas exclusive rights to develop and commercialize the investigational compound linaclotide in Japan, Indonesia, Korea, the Philippines, Taiwan, and Thailand.

New insight into how brain responds when people experience an unexpected or traumatic event

In a new study, psychologists at the University of Alabama at Birmingham (UAB) are able to see in detail for the first time how various regions of the human brain respond when people experience an unexpected or traumatic event. The study could lead to the creation of biological measures that could identify people with post-traumatic stress disorder (PTSD) or identify PTSD sufferers who would benefit from specific treatments.

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

As the number of children with severe COVID-19 illness grows, there is increasing urgency to ensure that potential treatments and vaccines are tested for safety and efficacy in children.

Read more Medical News

› Verified 3 days ago

Entity NameSouth Carolina Group Services, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1609212232
PECOS PAC ID: 1759525777
Enrollment ID: O20130912000800

News Archive

HHS awards $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines

United States Department of Health and Human Services has awarded a $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines for the U.S.

Uric acid may provide early clues to diabetic kidney disease

For patients with type 1 diabetes, increased levels of uric acid in the blood may be an early sign of diabetic kidney disease - appearing before any significant change in urine albumin level, the standard screening test, reports a study in the May 2008 issue of the Clinical Journal of the American Society of Nephrology.

Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia

Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that they have entered into an agreement providing Astellas exclusive rights to develop and commercialize the investigational compound linaclotide in Japan, Indonesia, Korea, the Philippines, Taiwan, and Thailand.

New insight into how brain responds when people experience an unexpected or traumatic event

In a new study, psychologists at the University of Alabama at Birmingham (UAB) are able to see in detail for the first time how various regions of the human brain respond when people experience an unexpected or traumatic event. The study could lead to the creation of biological measures that could identify people with post-traumatic stress disorder (PTSD) or identify PTSD sufferers who would benefit from specific treatments.

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

As the number of children with severe COVID-19 illness grows, there is increasing urgency to ensure that potential treatments and vaccines are tested for safety and efficacy in children.

Read more Medical News

› Verified 3 days ago

Entity NameSoutheastern Hospitalist Services Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1003280108
PECOS PAC ID: 3476855420
Enrollment ID: O20160125000378

News Archive

HHS awards $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines

United States Department of Health and Human Services has awarded a $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines for the U.S.

Uric acid may provide early clues to diabetic kidney disease

For patients with type 1 diabetes, increased levels of uric acid in the blood may be an early sign of diabetic kidney disease - appearing before any significant change in urine albumin level, the standard screening test, reports a study in the May 2008 issue of the Clinical Journal of the American Society of Nephrology.

Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia

Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that they have entered into an agreement providing Astellas exclusive rights to develop and commercialize the investigational compound linaclotide in Japan, Indonesia, Korea, the Philippines, Taiwan, and Thailand.

New insight into how brain responds when people experience an unexpected or traumatic event

In a new study, psychologists at the University of Alabama at Birmingham (UAB) are able to see in detail for the first time how various regions of the human brain respond when people experience an unexpected or traumatic event. The study could lead to the creation of biological measures that could identify people with post-traumatic stress disorder (PTSD) or identify PTSD sufferers who would benefit from specific treatments.

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

As the number of children with severe COVID-19 illness grows, there is increasing urgency to ensure that potential treatments and vaccines are tested for safety and efficacy in children.

Read more Medical News

› Verified 3 days ago

Entity Name24 On Physicians Of Sc Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144877655
PECOS PAC ID: 5890127344
Enrollment ID: O20191121001203

News Archive

HHS awards $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines

United States Department of Health and Human Services has awarded a $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines for the U.S.

Uric acid may provide early clues to diabetic kidney disease

For patients with type 1 diabetes, increased levels of uric acid in the blood may be an early sign of diabetic kidney disease - appearing before any significant change in urine albumin level, the standard screening test, reports a study in the May 2008 issue of the Clinical Journal of the American Society of Nephrology.

Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia

Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that they have entered into an agreement providing Astellas exclusive rights to develop and commercialize the investigational compound linaclotide in Japan, Indonesia, Korea, the Philippines, Taiwan, and Thailand.

New insight into how brain responds when people experience an unexpected or traumatic event

In a new study, psychologists at the University of Alabama at Birmingham (UAB) are able to see in detail for the first time how various regions of the human brain respond when people experience an unexpected or traumatic event. The study could lead to the creation of biological measures that could identify people with post-traumatic stress disorder (PTSD) or identify PTSD sufferers who would benefit from specific treatments.

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

As the number of children with severe COVID-19 illness grows, there is increasing urgency to ensure that potential treatments and vaccines are tested for safety and efficacy in children.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Kent J Stock is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Kent J Stock, DO
1938 B Charlie Hall Blvd,
Charleston, SC 29414-6099

Ph: (843) 402-0227
Dr Kent J Stock, DO
1938 B Charlie Hall Blvd,
Charleston, SC 29414-5837

Ph: (843) 402-0227

News Archive

HHS awards $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines

United States Department of Health and Human Services has awarded a $97 million contract to Sanofi Pasteur to speed the production process for new influenza vaccines for the U.S.

Uric acid may provide early clues to diabetic kidney disease

For patients with type 1 diabetes, increased levels of uric acid in the blood may be an early sign of diabetic kidney disease - appearing before any significant change in urine albumin level, the standard screening test, reports a study in the May 2008 issue of the Clinical Journal of the American Society of Nephrology.

Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia

Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that they have entered into an agreement providing Astellas exclusive rights to develop and commercialize the investigational compound linaclotide in Japan, Indonesia, Korea, the Philippines, Taiwan, and Thailand.

New insight into how brain responds when people experience an unexpected or traumatic event

In a new study, psychologists at the University of Alabama at Birmingham (UAB) are able to see in detail for the first time how various regions of the human brain respond when people experience an unexpected or traumatic event. The study could lead to the creation of biological measures that could identify people with post-traumatic stress disorder (PTSD) or identify PTSD sufferers who would benefit from specific treatments.

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

As the number of children with severe COVID-19 illness grows, there is increasing urgency to ensure that potential treatments and vaccines are tested for safety and efficacy in children.

Read more News

› Verified 3 days ago


Internal Medicine Doctors in Charleston, SC

Dr. Jeffrey Peter Yourshaw, M.D.
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 169 Ashley Ave, Room 202 Main Hospital Msc 333, Charleston, SC 29425
Phone: 843-876-4807    Fax: 843-876-4809
Jennifer Lee Martin, D.O.
Infectious Disease
Medicare: Not Enrolled in Medicare
Practice Location: 171 Ashley Ave, Charleston, SC 29425
Phone: 843-792-1414    
Nikko Rowe Asuncion Tabliago, MD
Infectious Disease
Medicare: Medicare Enrolled
Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425
Phone: 843-792-2575    
Moses K Asempah, MD
Infectious Disease
Medicare: Medicare Enrolled
Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425
Phone: 717-491-3745    
Paige Nicole Laverick, PA-C
Infectious Disease
Medicare: Medicare Enrolled
Practice Location: 171 Ashley Ave, Charleston, SC 29425
Phone: 843-792-1414    
Amit Agrawal, MD
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 171 Ashley Ave, Charleston, SC 29425
Phone: 843-792-1414    
Yevgeniy Gelfand, MD
Infectious Disease
Medicare: Medicare Enrolled
Practice Location: 67 President St, Charleston, SC 29425
Phone: 843-792-0111    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.